Frontlight ResearchEarly access
Trial site
Ruijin Hospital of Shanghai Jiaotong University School of Medicine
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Lupus (SLE)3 trials
- Ulcerative colitis2 trials
- Fatty liver disease (MASLD/MASH)1 trial
- Gastric and oesophageal cancer1 trial
- IgA nephropathy1 trial
- Metastatic breast cancer1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 36 trials
- Phase 22 trials
- Phase 2/31 trial
- Status
- Active, not recruiting5 trials
- Completed2 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Biogen2 trials
- Takeda2 trials
- Abivax S.A.1 trial
- Astellas Pharma Global Development, Inc.1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- and 2 more
Running trials
Recruiting
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Active, not recruiting
Active, not recruiting
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
Active, not recruiting
Active, not recruiting
Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)1 recruiting
- IgA nephropathy1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 14 Nov 2026